CELH
Celsius Holdings, Inc.
CELH has the edge over USNA overall, supported by stronger fundamentals and stronger valuation.
USNA
USANA Health Sciences, Inc.
USNA trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
USNA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
USNA's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
USNA PE Valuation
USNA has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over USNA on the outlook, with more favorable earnings and revenue expectations.
USNA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect USNA's earnings and profitability to decline, with its revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over USNA on earnings quality, reporting a profit while its opponent remains loss making.
USNA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.01 | — |
| Q3 2026 | -$1.12 | -227% |
| Q2 2026 | -$1.18 | -166% |
| Q1 2026 | $0.50 | -73% |
| Q4 2025 | $0.58 | -74% |
| Q3 2025 | $0.88 | -69% |
| Q2 2025 | $1.80 | -37% |
| Q1 2025 | $1.82 | -43% |
| Q4 2024 | $2.19 | -34% |
USNA has swung to a loss: it lost $1.12 per share over the past year, after a profit the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over USNA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over USNA on profitability, with a higher operating margin.
USNA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $205.9M | -3.6% |
| Q2 2026 | $223.3M | -5.3% |
| Q1 2026 | $250.2M | +0.3% |
| Q4 2025 | $226.2M | +5.9% |
| Q3 2025 | $213.7M | +6.7% |
| Q2 2025 | $235.8M | +11% |
| Q1 2025 | $249.5M | +9.5% |
| Q4 2024 | $213.6M | -3.4% |
USNA's revenue fell from its 2021 peak and has held roughly level since: $206M last quarter, down 3.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.7% | -1.3 points |
| Q2 2026 | -9% | -16 points |
| Q1 2026 | 5.5% | -0.7 points |
| Q4 2025 | 1.7% | -2.1 points |
| Q3 2025 | 0.6% | -7.2 points |
| Q2 2025 | 7.1% | -1.3 points |
| Q1 2025 | 6.3% | -4.5 points |
| Q4 2024 | 3.8% | -7.1 points |
USNA's operating margin was −0.7% last quarter, down 1.3 points from the same quarter a year ago, near the bottom of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over USNA on cash flow, with more consistent year-over-year improvement.
USNA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.4M | +$13.6M |
| Q2 2026 | $20.2M | +180% |
| Q1 2026 | $7.1M | -44% |
| Q4 2025 | -$6.2M | -255% |
| Q3 2025 | -$5.2M | -119% |
| Q2 2025 | $7.2M | +35% |
| Q1 2025 | $12.7M | -12% |
| Q4 2024 | $4M | -79% |
USNA still generates free cash flow, though less than at its 2019 peak: $30M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over USNA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
USNA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +12K shares |
| 1 year | +1.1% | +205K shares |
| 3 years | -4.5% | -874K shares |
| 5 years | -8.2% | -1.7M shares |
| Available history | -19% | -4.3M shares |
USNA has 18M diluted shares, up 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $15.2M |
| Q1 2025 | $12.3M |
| Q4 2024 | — |
USNA hasn't bought back shares in the past year.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
USNA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -6.2x | Net Cash |
| Q2 2026 | -5.4x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -2.0x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
USNA has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
USNA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.5 | Neutral |
| Stochastic | 10.5 | Oversold |
USNA's weekly RSI is 34 (neutral) and its Stochastic is 11 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
USNA PE vs Consumer Defensive Sector
| Metric | USNA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
USNA has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over USNA on trend strength, trading above more of its moving averages.
USNA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.3 | 11% below |
| 20 week MA | $16.2 | 21% below |
| 50 week MA | $18.2 | 30% below |
| 100 week MA | $23.5 | 46% below |
| 200 week MA | $37.5 | 66% below |
USNA is in a downtrend: it's below all five of its weekly moving averages, and 66% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over USNA on returns for 2026, with the stronger performance.
USNA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $80.0 | $77.8 | -2.8% |
| 2021 | $77.8 | $100.5 | +29% |
| 2022 | $100.5 | $54.4 | -46% |
| 2023 | $54.4 | $53.6 | -1.5% |
| 2024 | $53.6 | $35.7 | -33% |
| 2025 | $35.7 | $19.8 | -44% |
| 2026 YTD | $19.8 | $12.7 | -36% |
USNA has finished four years in a row lower, and it's down 36% so far in 2026.